Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating
Reverse-phase high-performance liquid chromatography (RP-HPLC) approach for Lapatinib in pharmaceutical dosage form development and validation. Reverse phase chromatography is easy, practical, and superior in terms of effectiveness, stability, and repeatability. Lapatinib was chosen to be separated...
Gespeichert in:
Veröffentlicht in: | Research journal of pharmacy and technology 2023-07, Vol.16 (7), p.3125-3131 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3131 |
---|---|
container_issue | 7 |
container_start_page | 3125 |
container_title | Research journal of pharmacy and technology |
container_volume | 16 |
creator | Katolkar, Parimal Gaydhane, Nikita Vidhate, Swati Gattewar, Apurva Motghare, Apeksha Baheti, Jagdish |
description | Reverse-phase high-performance liquid chromatography (RP-HPLC) approach for Lapatinib in pharmaceutical dosage form development and validation. Reverse phase chromatography is easy, practical, and superior in terms of effectiveness, stability, and repeatability. Lapatinib was chosen to be separated using the C18 column, a 250 x 4.6 mm column with 5.0µm particle packing. As lapatinib was exhibiting good peak morphologies and a large amount of resolution, it was created with a mobile phase of water, methanol, and trifluroacetic acid (30:70:0.1) v/v. The analytes were detected at 262nm using a UV detector while the mobile phase was flowing at 1.1 ml/min. Specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation were used to develop the method and validate it.The method demonstrated a dynamic linear response at 25-75 µg/ml and was shown to be linear with a correlation coefficient (r2) of above 0.999 and limits of detection and quantitation (LOD and LOQ) of 0.45 and 1.35µg, respectively. Degradation of the sample was used to establish the stability indicating RP-HPLC procedures, which were then compared to standards. The relative standard deviation as a percentage was also less than 2%, demonstrating the suggested method's high level of precision. |
doi_str_mv | 10.52711/0974-360X.2023.00514 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2908826772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2908826772</sourcerecordid><originalsourceid>FETCH-LOGICAL-c144t-b85b197c207b3a2f26e30dbef29e3f8363840518a163b0af060306b2feb298243</originalsourceid><addsrcrecordid>eNo9kFtLwzAUx4MoOOY-ghDwuTOXNk0fx9zcoKJ4w7eQtInL6JraZkrBD2-2ys7LuZ_D_wfANUbThKQY36IsjSPK0MeUIEKnCCU4PgOjU_n8FGN-CSZdt0XBGE9IzEfgd1bLqve2kBV80H7jSninv3Xlmp2uPZR1Cd9lZUvprauhcS1cdN7uhtQZmMsmxLVV0NZw6drdvhp6qofPT9HqKZ_DH-s38MVLZSvre7iuy_AuLH1egQsjq05P_v0YvC0Xr_NVlD_er-ezPCpwHPtI8UThLC0IShWVxBCmKSqVNiTT1HDKKI-Dai4xowpJgxiiiClitCIZJzEdg5vhbtO6r73uvNi6fRuEd4JkiHPC0pSEqWSYKlrXda02ommD0rYXGIkja3EAKQ5QxYG1OLKmf1W5cd8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2908826772</pqid></control><display><type>article</type><title>Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Katolkar, Parimal ; Gaydhane, Nikita ; Vidhate, Swati ; Gattewar, Apurva ; Motghare, Apeksha ; Baheti, Jagdish</creator><creatorcontrib>Katolkar, Parimal ; Gaydhane, Nikita ; Vidhate, Swati ; Gattewar, Apurva ; Motghare, Apeksha ; Baheti, Jagdish</creatorcontrib><description>Reverse-phase high-performance liquid chromatography (RP-HPLC) approach for Lapatinib in pharmaceutical dosage form development and validation. Reverse phase chromatography is easy, practical, and superior in terms of effectiveness, stability, and repeatability. Lapatinib was chosen to be separated using the C18 column, a 250 x 4.6 mm column with 5.0µm particle packing. As lapatinib was exhibiting good peak morphologies and a large amount of resolution, it was created with a mobile phase of water, methanol, and trifluroacetic acid (30:70:0.1) v/v. The analytes were detected at 262nm using a UV detector while the mobile phase was flowing at 1.1 ml/min. Specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation were used to develop the method and validate it.The method demonstrated a dynamic linear response at 25-75 µg/ml and was shown to be linear with a correlation coefficient (r2) of above 0.999 and limits of detection and quantitation (LOD and LOQ) of 0.45 and 1.35µg, respectively. Degradation of the sample was used to establish the stability indicating RP-HPLC procedures, which were then compared to standards. The relative standard deviation as a percentage was also less than 2%, demonstrating the suggested method's high level of precision.</description><identifier>ISSN: 0974-3618</identifier><identifier>EISSN: 0974-360X</identifier><identifier>EISSN: 0974-306X</identifier><identifier>DOI: 10.52711/0974-360X.2023.00514</identifier><language>eng</language><publisher>Raipur: A&V Publications</publisher><subject>Accuracy ; Acids ; Breast cancer ; Cell growth ; Chromatography ; Inhibitor drugs ; Particle size ; Sensors</subject><ispartof>Research journal of pharmacy and technology, 2023-07, Vol.16 (7), p.3125-3131</ispartof><rights>Copyright A&V Publications Jul 2023</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c144t-b85b197c207b3a2f26e30dbef29e3f8363840518a163b0af060306b2feb298243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Katolkar, Parimal</creatorcontrib><creatorcontrib>Gaydhane, Nikita</creatorcontrib><creatorcontrib>Vidhate, Swati</creatorcontrib><creatorcontrib>Gattewar, Apurva</creatorcontrib><creatorcontrib>Motghare, Apeksha</creatorcontrib><creatorcontrib>Baheti, Jagdish</creatorcontrib><title>Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating</title><title>Research journal of pharmacy and technology</title><description>Reverse-phase high-performance liquid chromatography (RP-HPLC) approach for Lapatinib in pharmaceutical dosage form development and validation. Reverse phase chromatography is easy, practical, and superior in terms of effectiveness, stability, and repeatability. Lapatinib was chosen to be separated using the C18 column, a 250 x 4.6 mm column with 5.0µm particle packing. As lapatinib was exhibiting good peak morphologies and a large amount of resolution, it was created with a mobile phase of water, methanol, and trifluroacetic acid (30:70:0.1) v/v. The analytes were detected at 262nm using a UV detector while the mobile phase was flowing at 1.1 ml/min. Specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation were used to develop the method and validate it.The method demonstrated a dynamic linear response at 25-75 µg/ml and was shown to be linear with a correlation coefficient (r2) of above 0.999 and limits of detection and quantitation (LOD and LOQ) of 0.45 and 1.35µg, respectively. Degradation of the sample was used to establish the stability indicating RP-HPLC procedures, which were then compared to standards. The relative standard deviation as a percentage was also less than 2%, demonstrating the suggested method's high level of precision.</description><subject>Accuracy</subject><subject>Acids</subject><subject>Breast cancer</subject><subject>Cell growth</subject><subject>Chromatography</subject><subject>Inhibitor drugs</subject><subject>Particle size</subject><subject>Sensors</subject><issn>0974-3618</issn><issn>0974-360X</issn><issn>0974-306X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo9kFtLwzAUx4MoOOY-ghDwuTOXNk0fx9zcoKJ4w7eQtInL6JraZkrBD2-2ys7LuZ_D_wfANUbThKQY36IsjSPK0MeUIEKnCCU4PgOjU_n8FGN-CSZdt0XBGE9IzEfgd1bLqve2kBV80H7jSninv3Xlmp2uPZR1Cd9lZUvprauhcS1cdN7uhtQZmMsmxLVV0NZw6drdvhp6qofPT9HqKZ_DH-s38MVLZSvre7iuy_AuLH1egQsjq05P_v0YvC0Xr_NVlD_er-ezPCpwHPtI8UThLC0IShWVxBCmKSqVNiTT1HDKKI-Dai4xowpJgxiiiClitCIZJzEdg5vhbtO6r73uvNi6fRuEd4JkiHPC0pSEqWSYKlrXda02ommD0rYXGIkja3EAKQ5QxYG1OLKmf1W5cd8</recordid><startdate>20230701</startdate><enddate>20230701</enddate><creator>Katolkar, Parimal</creator><creator>Gaydhane, Nikita</creator><creator>Vidhate, Swati</creator><creator>Gattewar, Apurva</creator><creator>Motghare, Apeksha</creator><creator>Baheti, Jagdish</creator><general>A&V Publications</general><scope>AAYXX</scope><scope>CITATION</scope><scope>04Q</scope><scope>04S</scope><scope>04W</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20230701</creationdate><title>Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating</title><author>Katolkar, Parimal ; Gaydhane, Nikita ; Vidhate, Swati ; Gattewar, Apurva ; Motghare, Apeksha ; Baheti, Jagdish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c144t-b85b197c207b3a2f26e30dbef29e3f8363840518a163b0af060306b2feb298243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Accuracy</topic><topic>Acids</topic><topic>Breast cancer</topic><topic>Cell growth</topic><topic>Chromatography</topic><topic>Inhibitor drugs</topic><topic>Particle size</topic><topic>Sensors</topic><toplevel>online_resources</toplevel><creatorcontrib>Katolkar, Parimal</creatorcontrib><creatorcontrib>Gaydhane, Nikita</creatorcontrib><creatorcontrib>Vidhate, Swati</creatorcontrib><creatorcontrib>Gattewar, Apurva</creatorcontrib><creatorcontrib>Motghare, Apeksha</creatorcontrib><creatorcontrib>Baheti, Jagdish</creatorcontrib><collection>CrossRef</collection><collection>India Database</collection><collection>India Database: Business</collection><collection>India Database: Science & Technology</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Research journal of pharmacy and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katolkar, Parimal</au><au>Gaydhane, Nikita</au><au>Vidhate, Swati</au><au>Gattewar, Apurva</au><au>Motghare, Apeksha</au><au>Baheti, Jagdish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating</atitle><jtitle>Research journal of pharmacy and technology</jtitle><date>2023-07-01</date><risdate>2023</risdate><volume>16</volume><issue>7</issue><spage>3125</spage><epage>3131</epage><pages>3125-3131</pages><issn>0974-3618</issn><eissn>0974-360X</eissn><eissn>0974-306X</eissn><abstract>Reverse-phase high-performance liquid chromatography (RP-HPLC) approach for Lapatinib in pharmaceutical dosage form development and validation. Reverse phase chromatography is easy, practical, and superior in terms of effectiveness, stability, and repeatability. Lapatinib was chosen to be separated using the C18 column, a 250 x 4.6 mm column with 5.0µm particle packing. As lapatinib was exhibiting good peak morphologies and a large amount of resolution, it was created with a mobile phase of water, methanol, and trifluroacetic acid (30:70:0.1) v/v. The analytes were detected at 262nm using a UV detector while the mobile phase was flowing at 1.1 ml/min. Specificity, linearity, accuracy, precision, robustness, limit of detection, and limit of quantitation were used to develop the method and validate it.The method demonstrated a dynamic linear response at 25-75 µg/ml and was shown to be linear with a correlation coefficient (r2) of above 0.999 and limits of detection and quantitation (LOD and LOQ) of 0.45 and 1.35µg, respectively. Degradation of the sample was used to establish the stability indicating RP-HPLC procedures, which were then compared to standards. The relative standard deviation as a percentage was also less than 2%, demonstrating the suggested method's high level of precision.</abstract><cop>Raipur</cop><pub>A&V Publications</pub><doi>10.52711/0974-360X.2023.00514</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0974-3618 |
ispartof | Research journal of pharmacy and technology, 2023-07, Vol.16 (7), p.3125-3131 |
issn | 0974-3618 0974-360X 0974-306X |
language | eng |
recordid | cdi_proquest_journals_2908826772 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Accuracy Acids Breast cancer Cell growth Chromatography Inhibitor drugs Particle size Sensors |
title | Analytical Method Development and Validation for Estimation of Lapatinib in Formulation by RP-HPLC with Stability Indicating |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T17%3A25%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analytical%20Method%20Development%20and%20Validation%20for%20Estimation%20of%20Lapatinib%20in%20Formulation%20by%20RP-HPLC%20with%20Stability%20Indicating&rft.jtitle=Research%20journal%20of%20pharmacy%20and%20technology&rft.au=Katolkar,%20Parimal&rft.date=2023-07-01&rft.volume=16&rft.issue=7&rft.spage=3125&rft.epage=3131&rft.pages=3125-3131&rft.issn=0974-3618&rft.eissn=0974-360X&rft_id=info:doi/10.52711/0974-360X.2023.00514&rft_dat=%3Cproquest_cross%3E2908826772%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2908826772&rft_id=info:pmid/&rfr_iscdi=true |